7 / 182
ABOUT US
One
126
YEARS OF MILESTONES
1890
EJ Adcock Pharmacy
opened its doors in
Krugersdorp.
1937
Ingram’s Camphor
Cream was launched.
1948
Relationship established
with Baxter Healthcare.
1949
Adcock Ingram,
first pharmaceutical
company, listed on the
Johannesburg Stock
Exchange (JSE).
1978
Tiger Oats Limited
acquired 74%
shareholding in Adcock
Ingram.
1979
The Critical Care
division commissioned
South Africa’s first
medical grade plastics
facility.
1987
Adcock Ingram
acquired the Mer-
National Division from
Dow Chemicals Africa
and Sterling Winthrop.
These acquisitions
strengthened the
Group’s range in the
Over the Counter (OTC)
market with brands
such as Panado.
Adcock Ingram also
launched Myprodol, a
locally developed and
patented analgesic and
anti-inflammatory.
1994
Adcock Ingram
acquired Leppin, Laser,
Pharmatec, Zurich
Pharmaceuticals, Covan
Pharmaceuticals and
Salters, and leading OTC
brands in Zimbabwe.
1996
The merger
with Premier
Pharmaceuticals
created South Africa’s
leading supplier of
healthcare products.
1999
Construction of a
R25 million research
and development
centre at Aeroton.
2000
Adcock Ingram became
a wholly-owned
subsidiary of Tiger
Brands and was delisted
from the JSE.
2003
Acquisition of
Citro-Soda. Bought
cardiovascular and
central nervous system
portfolio (Parke-Med)
from Pfizer Laboratories.
2007
Adcock Ingram
launched its range of
generic ARV products.
2008
Adcock Ingram
unbundled from Tiger
Brands and relisted on
the JSE.
Joint venture with an
Indian partner led to
the formation of Adcock
Ingram in Bangalore.
2010
Concluded BEE equity
transaction which
raised Adcock Ingram to
a Level 4 empowerment
contributor.
Entered into strategic
collaboration with
various multinational
companies.
2012
Completed the high-
volume liquids facility in
Clayville.
2014
The Bidvest Group
Limited acquired 29.4%
of the shares in the
Group.
FIVE
SIX
THREE
ONE
FOUR
TWO
| 3
Integrated Report 2016